Table 3.
Patients' reported symptoms in the irradiated field.
| Rash and/or erythema | |
|---|---|
| No | 341 (94.5%) |
| Yes | 20 (5.5%) |
| Itching | |
| None | 349 (96.7%) |
| Mild | 6 (1.7%) |
| Moderate | 2 (0.5%) |
| Severe | 3 (0.8%) |
| Very severe | 1 (0.3%) |
| Skin darkening | |
| Yes | 2 (0.6%) |
| No | 359 (99.4%) |
| Pain | |
| Frequency | |
| Never | 346 (95.8%) |
| Rarely | 2 (0.6%) |
| Occasionally | 5 (1.4%) |
| Frequently | 5 (1.4%) |
| Almost constantly | 3 (0.8%) |
| Severity | |
| None | 346 (95.8%) |
| Mild | 5 (1.4%) |
| Moderate | 7 (1.9%) |
| Severe | 2 (0.6%) |
| Very severe | 1 (0.3%) |
| Interference with usual/daily activity | |
| Not at all | 351 (97.2%) |
| A little bit | 6 (1.7%) |
| Somewhat | 3 (0.8%) |
| Quite a bit | 1 (0.3%) |
| Very much | 0 |
| Breast swelling and tenderness | |
| None | 353 (97.8%) |
| Mild | 4 (1.1%) |
| Moderate | 3 (0.8%) |
| Severe | 1 (0.3%) |
| Very severe | 0 |
Patient reported effects in irradiated field were scored according the PRO-CTCAE scale.